TUMOUR INFLAMMATION

This adverse event was reported 112 times

These drugs are most commonly taken by patients reporting TUMOUR INFLAMMATION:

# Drug Count
0 ATEZOLIZUMAB 12
1 BEVACIZUMAB 12
2 RIBOCICLIB 12
3 ADALIMUMAB 9
4 CIPROFLOXACIN HYDROCHLORIDE 9
5 FULVESTRANT 9
6 LETROZOLE 9
7 METRONIDAZOLE 9
8 PEMBROLIZUMAB 9
9 CAPECITABINE 7
See all common drugs associated with TUMOUR INFLAMMATION

TUMOUR INFLAMMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LACTULOSE SOLUTION USP, 10 G/15 ML 1 0.0099
1 SACCHAROMYCES CEREVISIAE 6 0.0065
2 PLATINUM 2 0.0038
3 VIMSELTINIB 1 0.0018
4 ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 1 0.0018
5 EPCORITAMAB-BYSP 2 0.0015
6 PEXIDARTINIB HYDROCHLORIDE 1 0.0014
7 12%AZELAIC ACID 1 0.0012
8 DATOPOTAMAB DERUXTECAN 1 0.0012
9 NIROGACESTAT 1 0.0011
See all drugs enriched for association with TUMOUR INFLAMMATION